[Federal Register Volume 67, Number 84 (Wednesday, May 1, 2002)]
[Notices]
[Pages 21687-21691]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10681]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02044]


A Community-Based Intervention with Opinion Leaders to Achieve 
Syphilis Elimination; Notice of Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year FY 2002 funds for a cooperative agreement 
research program for a Community-Based Intervention with Popular 
Opinion Leaders (CPOL) to Achieve Syphilis Elimination. This program 
addresses the ``Healthy People 2010'' objectives for Sexually 
Transmitted Diseases (STDs). This project also addresses the ``National 
Plan to Eliminate Syphilis from the United States'' pertaining to the 
strengthening of community involvement and partnerships and enhanced 
health promotion. For a copy of the ``National Plan to Eliminate 
Syphilis from the United States,'' visit the Internet site: http://www.cdc.gov/stopsyphillis.
    It is intended that this research program will be conducted in 
communities that are located in high morbidity areas (HMAs) for 
syphilis as defined by the CDC on Attachment A. Funding is available 
for two demonstration sites for up to three years.
    The goal of this research program is to implement and evaluate a 
community level intervention to prevent transmission of primary and 
secondary syphilis in rural and urban communities by training key 
community members (i.e. opinion leaders) within the affected 
communities to promote risk reduction and health seeking behaviors. The 
intervention that will be evaluated in this demonstration project is 
the Popular Opinion Leader (POL) model (Kelly, St. Lawrence, Stevenson, 
et al, 1992). For the purposes of this announcement and research 
program, POL will be referred to as the Community Popular Opinion 
Leader (CPOL) model. The CPOL model is based on Diffusion of Innovation 
Theory (Rogers, 1985), which suggests that changes can be rapidly 
disseminated and subsequently adopted by identifying, enlisting, and 
training opinion leaders within the affected community to endorse the 
desired behaviors. The Community Opinion Leaders function as ``agents 
of change'' by disseminating and personally endorsing health promotion 
(e.g. syphilis prevention) messages. They utilize their ability to 
influence other community members and facilitate changes in social 
norms and behaviors by sharing factual information, expressing their 
concern for syphilis prevention, and endorsing and modeling effective 
behavior change strategies within their social and sexual networks.
    It has been empirically determined that the CPOL model is effective 
in reducing HIV-related sexual risk of men who have sex with men (MSM) 
in U.S. cities (e.g. Kelly, St. Lawrence, Stevenson, Hauth, et al., 
1992; Kelly, Murphy, Sikkema, McAuliffe et al., 1997), and ethnic 
minority women who lived in urban low-income housing (Sikkema, Kelly, 
Winett, Solomon et al., 2000). The Popular Opinion Leader model is also 
included in the ``Compendium of HIV Prevention Interventions with 
Evidence of Effectiveness.'' For a copy of the ``Compendium of HIV 
Interventions,'' visit the Internet site: http://www.cdcnpin.org/Reports/HIVcompendium.pdf. Although the CPOL model is effective in 
reducing HIV risk, its efficacy in preventing STDs other than HIV has 
never been empirically determined.
    The goal of this research project is to evaluate the utility of the 
CPOL model in preventing primary and secondary syphilis in rural and 
urban HMA communities. It is required that the proposed research 
program be implemented in communities located in HMAs for syphilis. 
Applications should target heterosexually active adults at risk for 
syphilis due to sexual risk behaviors. It is also required that the 
program include collaboration between the local health department, 
community-based organizations (CBOs) that work directly with the at-
risk population, and university researchers experienced in designing, 
implementing, and evaluating community-level interventions for STD/HIV 
prevention.

Overall Study Objectives

    The overall objectives for this research program are:
    (1) To design and implement a community-level intervention to 
prevent syphilis based on the (CPOL) model and using an experimental 
design.
    (2) To target the CPOL intervention for heterosexually active 
adults at risk for syphilis infection and living in counties identified 
as HMAs.
    (3) To evaluate the effectiveness of the CPOL intervention by 
identifying changes in attitudes, beliefs, health care seeking, sexual 
risk behaviors, and syphilis incidence in the intervention community, 
as compared to a similar community that does not receive the CPOL 
intervention.

B. Eligible Applicants

    Applications may be submitted by public and private nonprofit 
organizations and by governments and their agencies including public 
and nonprofit faith-based organizations; that is, universities, 
colleges, research institutions, hospitals, other public and private 
nonprofit organizations, State and local governments or their bona fide 
agents, including the District of Columbia, the Commonwealth of Puerto 
Rico, and federally recognized Indian Tribal Governments, Indian 
Tribes, or Indian Tribal Organizations.

    Note: Title 2 of the United State Code Section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

    Other eligibility criterias include the following:
    (1) Applicants must use the CPOL model as a basis for the community 
level intervention.
    (2) Applicants must target male and female heterosexually active 
adults at-risk for syphilis infection.
    (3) Applicants must implement the research program in two rural or 
two urban communities within project areas that are defined as (HMAs) 
for syphilis and received 2002 funding for syphilis elimination (see 
Attachment A).
    (4) The two urban or two rural communities must be a matched pair, 
similar in population and demographic characteristics. The matched pair 
should also be located in the same state. One community must serve as 
the study community and have the interventions implemented immediately, 
while the matched community must serve as the control and have the 
interventions offered after the completion of the research program.
    (5) The locations of the communities, within each matched pair of 
urban or rural sites, must be such that activities implemented in one 
community are unlikely to have any impact in the other.

[[Page 21688]]

C. Availability of Funds

    Approximately $400,000 is available in FY 2002 to fund up to two 
awards. It is expected that the average award will be $200,000. It is 
expected that one application proposing two matched urban sites and one 
application proposing two matched rural sites will be awarded. It is 
expected that awards will be made on or before September 30, 2002 and 
will be made for a 12 month budget period within a project period of up 
to three years. Funding estimates may change depending upon the 
availability of funds.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

1. Use of Funds

    Funds are awarded for a specifically defined purpose and may not be 
used for any other purpose or program. Funds may be used to support 
personnel and to purchase equipment, supplies and services directly 
related to project activities. Funds may not be used to supplant state 
or local health department funds, provide direct medical care (e.g., 
purchase of pharmaceuticals) or prevention case management.

2. Funding Preferences

    Funds may be awarded in such a way as to achieve geographic 
distribution, and representation of counties affected by high syphilis 
morbidity.

D. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. Recipient 
Activities, and CDC will be responsible for activities listed under 2. 
CDC Activities.

1. Recipient Activities

    a. Design and conduct a research program to address the study 
objectives in Section A by implementing and evaluating a community-
level intervention to prevent syphilis using the er (CPOL) model and 
targeting heterosexually active adults at risk for syphilis infection 
in urban or rural HMA communities.
    b. Identify appropriate personnel for the project. Skills and 
experience of project personnel must include: (1) Familiarity with 
syphilis transmission, treatment and prevention. (2) Experience working 
within communities experiencing high rates of syphilis. (3) Experience 
working with community-based organizations that serve target population 
living in high syphilis morbidity areas. (4) Experience implementing 
and managing theory-driven and community based intervention projects. 
(5) Evaluation expertise.
    c. Have in place or establish collaborative relationships with 
appropriate partners to accomplish project goals. Partnerships must 
include health departments, university based researchers and community 
based organizations that serve and are able to access and work with at-
risk heterosexually active men and women in the targeted communities.
    d. Collaborate with other recipients in developing and collecting a 
common set of core variables to permit systematic comparisons.
    e. Collaborate with other recipients and CDC during the 
development, implementation and evaluation of the project.
    f. Collaborate with other recipients and CDC to disseminate interim 
reports of research activities to regional, state and local partners.
    g. Submit and obtain approval of the study protocols by the 
recipient's local institutional review board(s) and the CDC 
Institutional Review Board (IRB). Activities must be conducted in 
compliance with Protection of Human Subjects (45 CFR part 46).
    h. Establish procedures to maintain the rights and confidentiality 
of all study participants, including securing any assurances necessary 
to conduct research involving human subjects.
    i. Conduct local data management activities including data 
collection and management. Data collection may include street intercept 
interviews, focused individual interviews, role play assessment, paper 
and pencil measures, and process measures. Management of the data will 
include security of data, assurance of participant confidentially, data 
entry, and timely forwarding of data to the CDC project officer.
    j. Analyze and disseminate results through reports, presentations, 
and publications.
    k. Applicants are required to provide Measures of Effectiveness 
that will demonstrate the accomplishment of the various identified 
objectives of the grant. Measures must be objective/quantitative and 
must measure the intended outcome. These Measures of Effectiveness 
shall be submitted with the application and shall be an element of the 
evaluation.

2. CDC Activities

    A cooperative agreement reflects an assistance relationship between 
the Federal Government and the recipient in which substantial 
programmatic involvement is anticipated about the scientific and/or 
technical management of this research and or technical management of 
this research during its performance. With this in mind, CDC will:
    a. Provide up-to-date scientific information, technical assistance, 
and guidance in the design and conduct of the research.
    b. Provide technical assistance to awardees in developing and 
collecting a common set of core variables to enable comparison between 
project areas. Collaborative activities may include assistance on the 
development of common data collection instruments and developing a 
centralized system for data management for the core set of data 
elements collected by each funded project area.
    c. Assist in the development of a common research protocol for 
annual IRB review by all cooperating institutions participating in the 
research project. The CDC IRB will review and approve the protocol 
initially and on at least an annual basis until the research project, 
including analyses, is completed.
    d. Assist in ensuring human subjects assurances are in place as 
needed.
    e. Provide technical assistance on data collection methods, 
sampling methodology, intervention delivery, and quality assurance.
    f. Assist in analysis and dissemination of results, including the 
preparation of manuscripts, as needed.
    g. Monitor and evaluate the scientific and operational 
accomplishments of the project. This will be accomplished through 
periodic site visits, telephone calls, electronic communication, 
technical reports and interim data analyses.
    h. Convene meetings of recipients for the exchange of information.

E. Content

Letter of Intent (LOI)

    A Letter of Intent (LOI) is required for this research program. The 
narrative should be no more than three single spaced pages, printed on 
one side, with one-inch margins, and unreduced font. Your LOI will be 
used to prepare for the special emphasis panel (SEP) that will review 
the scientific merit of the applications, and should include the 
following information: Program Announcement Number 02044; name and 
address of institution; name and telephone number of a contact person; 
specific objectives to be addressed by the proposed project; and a 
brief description of project plans. Although

[[Page 21689]]

an LOI is required, the terms of the LOI are not binding and will not 
be used in the review of the application.

Applications

    Applications must be developed in accordance with the information 
contained in this program announcement, the PHS 398 Grant Application, 
and the instructions provided in this section. Use the information in 
the Purpose, Program Requirements, and Evaluation Criteria to develop 
the application content. Your application will be evaluated on the 
criteria listed below, so it is important to address each, preferably 
in order, with sufficient detail. Applicants may submit only one 
proposal.
    The narrative should be no more than 25 double spaced pages, 
printed on one side, with one-inch margins, unreduced font, and a 
number on each page. Applications with more than 25 pages will be 
returned and not reviewed. Please provide only attachments or 
appendices that are directly relevant to this request for funding. The 
budget and attachments/appendices, including letters of support, are 
not included in the count for the 25-page limit. All pages, including 
appendices, should be numbered sequentially. To document eligibility, 
the narrative must contain the following sections in the order 
presented below:
1. Abstract (1 page recommended)
    Provide a brief abstract of the project. The abstract must reflect 
the project's focus and the length of the project period (maximum of 3 
years) for which assistance is being requested (see ``Availability of 
Funds'' for additional information).
2. Specific Aims/Objectives (1 page recommended)
    List the objectives and the specific research questions the 
application is intended to address. State the hypotheses to be tested.
3. Background and Significance (2-5 pages recommended)
    Briefly sketch the background leading to the present application, 
including the theoretical or conceptual framework, and evaluate 
existing knowledge. Additional information regarding syphilis 
elimination is included in Attachment B. Specifically document how the 
proposed intervention may impact on syphilis morbidity in the targeted 
communities. Describe any available STD or syphilis specific prevention 
services. Describe the syphilis morbidity in the proposed project 
locations. Describe the characteristics of the targeted communities 
including whether they are urban or rural. Provide evidence of the 
communities' urban or rural characteristics. State concisely the 
importance and health relevance of the research described in this 
application by relating the specific aims to the objectives.
4. Preliminary Studies (2-3 pages recommended)
    Use this section to provide an account of the research team 
members' preliminary studies pertinent to the application that will 
help to establish the experience and competence of the research team 
members to pursue this proposed project. Include information about the 
experience of the research team and its members with the target 
population, behavioral and/or community level interventions, 
evaluation, and history of collaboration with relevant community 
partners including CBO's. References to appropriate reports, 
presentations, publications and manuscripts submitted or accepted for 
publication may be listed and are not part of the page limitations. 
Five collated sets of no more than ten such items of background 
material may be submitted in an appendix.
5. Research Design and Methods (15-20 pages recommended)
    a. Describe the research design and the procedures to be used to 
accomplish the specific aims of the project. Applications must address 
heterosexually active men and women at risk for syphilis infection. 
Applications must include the CPOL model as the community level 
intervention. Communities in counties within HMA project areas must be 
matched, similar in population and demographic characteristics, while 
being geographically placed such that activities in the study community 
do not have an impact on the control community.
    b. Describe the intervention development process, content and 
delivery, including specific intervention protocols or plans for the 
development of intervention protocols. Also, include the intent to 
offer the intervention to the control communities after the completion 
of the research program. Applications must demonstrate a comprehensive 
understanding of the CPOL model and how it can be applied in a 
community affected by syphilis. The application must also include a 
description of how members of the target population will be involved in 
the intervention activities.
    c. Describe the recruitment, sampling, and retention plans.
    d. Describe the measures to be used to evaluate the community level 
impact of the intervention. Applications should include self-report, 
social cognitive, behavioral and biological measures. Outcomes should 
include: (1) Social cognitive outcomes (e.g. changes in attitudes and 
beliefs). (2) Behavioral outcomes (e.g. changes in health seeking 
behavior, sexual risk behavior, syphilis screening) (3) Biological 
outcomes (e.g. syphilis serology, other bacterial STDs) (4) Process 
outcomes (e.g. participant tracking of conversation initiations, 
opinion leader attendance at training sessions). (5) Morbidity outcomes 
(e.g., rates of syphilis and other STDs among members of the targeted 
community). Assessment of outcomes should be appropriate for the target 
population and community.
    e. Describe how the data will be collected. Sampling schemes should 
be the same in the study and control communities. Choose and justify 
the sample size(s) considering the principles of Diffusion Theory 
(Rogers, 1995) and the different outcomes of interest. Power 
calculations are not necessary for biological outcome measures.
    f. Describe the data analysis plan, including a justification for 
the statistical techniques chosen to analyze the intervention data.
    g. Describe quality assurance plans.
    h. Provide a tentative sequence or timetable for the project.
    i. Describe the nature and extent of collaboration with CDC and/or 
others during various phases of the project.
    j. Specific, measurable, and time-framed objectives.
6. Inclusion of Women and Racial and Ethnic Populations
    Describe the proposed plan for the inclusion of both sexes and 
racial and ethnic minority populations. Describe the proposed 
justification when representation is limited or absent. Include a 
statement as to whether the design of the study is adequate to measure 
differences when warranted.
7. Human Subject Involvement
    Describe procedures that will provide for the protection of human 
subjects, including procedures to obtain appropriate parental consent 
where necessary. List how these procedures adequately address the 
requirements of 45 CFR part 46 for the protection of human subjects.

[[Page 21690]]

F. Submission and Deadline

Letter of Intent (LOI)

    On or before June 1, 2002, submit the LOI to the Grants Management 
Specialist identified in the ``Where to Obtain Additional Information'' 
section of this announcement.

Application

    Submit the original and five copies of PHS-398 (OMB Number 0925-
0001) (adhere to the instructions on the Errata Instruction Sheet for 
PHS 398) and, if applicable, the Optional Form 310, ``Protection of 
Human Subjects Assurance Identification Certification Declaration''. 
Forms are available in the application kit and at the following 
Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    On or before July 15, 2002, submit the application to the Technical 
Information Management Section, Office of the Director, Procurement and 
Grants Office, 2920 Brandywine Road, Suite 3000, Atlanta, Georgia 
30341.
    Deadline: Applications shall be considered as meeting the deadline 
if they are either:
    1. Received on or before the deadline date; or
    2. Sent on or before the deadline date and received in time for 
submission to the independent review group. (Applicants must request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or U.S. Postal Service. Private 
metered postmarks will not be acceptable proof of timely mailing.)
    Late Applications: Applications that do not meet the criteria in 1. 
or 2. above will be returned to the applicant.

G. Evaluation Criteria

    Applications will be reviewed and evaluated only on the basis of 
the evidence submitted. Each application will be evaluated individually 
against the following criteria by an independent review group appointed 
by CDC. Applications will be reviewed by CDC for completeness and 
responsiveness to the purpose of this program announcement (as 
described in Section A), and as outlined under Eligible Applicants and 
Program Requirements. Incomplete applications, and applications that 
are not responsive, will be returned to the applicant without further 
consideration. It is important that the applicant's abstract reflects 
the project's focus, because the abstract will be used to help 
determine the responsiveness of the application.
    All applications will be independently reviewed for scientific 
merit to evaluate the methods and scientific quality of the 
application. Factors to be used to evaluate the application include:

1. Specific Aims (5 points)

    The specific aims of the research project, including the 
objectives, and documenting the hypotheses to be tested.

2. Background (10 points)

    The background of the project, i.e., the basis for the present 
proposal, the critical evaluation of existing knowledge, and 
identification of how the intervention will effect syphilis morbidity 
and its anticipated impact on the affected communities. The description 
of available STD or syphilis specific prevention services and the 
syphilis morbidity in the proposed project locations. A description of 
the targeted communities including evidence of the communities' urban 
or rural characteristics.

3. Significance (15 points)

    The significance and innovation from scientific and programmatic 
standpoints of the proposed research, including the operationalization 
of the theoretical model and conceptual framework for the research and 
the rigor and appropriateness with which the outcomes are evaluated.

4. Research Design and Methods (45 points)

    a. The adequacy of the proposed research design to address the 
overall objectives.
    b. Plans for the development of intervention content and delivery, 
including specific intervention protocols or plans for the development 
of intervention protocols, and how members of the target population are 
involved in that process.
    c. The recruitment and retention plan.
    d. The self-report, social-cognitive, behavioral and biological 
outcome measures to be assessed. Outcomes should include: (1) Social 
cognitive outcomes (e.g. changes in attitudes and beliefs). (2) 
Behavioral outcomes (e.g. changes in health seeking behavior, sexual 
risk behavior, syphilis screening). (3) Biological outcomes (e.g. 
syphilis serology, other bacterial STDs). (4) Process outcomes (e.g. 
participant tracking of conversation initiations, opinion leader 
attendance at training sessions). (5) Morbidity outcomes (e.g., rates 
of syphilis and other STDs among members of the targeted community). 
Assessment of outcomes should be appropriate for the target population 
and community.
    e. Describe how the data will be collected. Sampling schemes should 
be the same in the study and control communities. Choose and justify 
the sample size(s) considering the principles of Diffusion Theory 
(Rogers, 1995) and the different outcomes of interest. Power 
calculations are not necessary for biological outcome measures.
    f. The plan for data collection and data management, including 
quality assurance procedures.
    g. A statistical analysis plan appropriate to the intervention 
evaluation.
    h. The project time line.
    i. Measures of Effectiveness. The Peer Review Panel shall assure 
that measures set forth in the application are in accordance with CDC's 
performance plans (See Attachment 4 in the application kit).

5. Research Program Team (15 points)

    The qualifications and appropriateness of the proposed personnel to 
accomplish the proposed activities. Applications should include multi-
disciplinary teams, including (but not limited to) health department 
staff, experienced with syphilis transmission and prevention, staff 
from participating CBO's and university scientists. The combined 
members of the research team must demonstrate a history of familiarity 
with, access to, and success working with the target populations (e.g. 
high risk heterosexually active adults at risk for syphilis), delivery 
of behavioral and/or community level interventions, and evaluation 
expertise. This familiarity, access and success may be demonstrated 
through biographical sketches, previous studies, and letters of 
support. Applicants must demonstrate a collaborative relationship 
between the local health departments, CBOs, and university researchers. 
The degree of commitment and cooperation of proposed collaborators must 
be confirmed by letters of support detailing the nature and extent of 
the involvement.

6. Research Capacity (10 points)

    Availability of appropriate scientific oversight necessary to 
fulfill research program objectives. These will include development, 
implementation, and evaluation of the intervention, recruitment and 
retention of participants, and collection and management of project-
related data. The application should describe the experience and 
capacity of the project team, and should include curriculm vitae (CVs) 
and position descriptions for all key staff in an attachment.

[[Page 21691]]

7. Human Subjects (Not scored)

    Restate the strategies for the recruitment and retention of human 
subjects and how the applicant will obtain appropriate consent, when 
necessary. Are the procedures proposed adequate for the protection of 
human subjects and are they fully documented? Does the application 
adequately address the requirements of Title 45 CFR part 46 for the 
protection of human subjects? The degree to which the applicant has met 
the CDC Policy requirements regarding the inclusion of women, ethnic, 
and racial groups in the proposed research, including: (1) The proposed 
plan for the inclusion of both sexes and racial and ethnic minority 
populations for appropriate representation. (2) The proposed 
justification when representation is limited or absent (3) A statement 
as to whether the design of the study is adequate to measure 
differences when warranted.

8. Budget (Not scored)

    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of funds. All budget categories 
must be itemized and appropriately justified.

H. Other Requirements

Technical Reporting Requirements

    Provide CDC with original plus two copies of--
    1. Annual progress report (the results of the Measures of 
Effectiveness shall be a data requirement to be submitted with or 
incorporated into the progress report. See CDC's Performance Plans at 
internet site: http://www.cdc.gov/od/perfplan/2001perfplan).
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, See Attachment I in the 
application kit.

AR-1 Human Subjects Requirements
AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-5 HIV Program Review Panel Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status
AR-21 Small, Minority, And Women-owned Business
AR-22 Research Integrity

I. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 318 and 318A of the 
Public Health Service Act (42 U.S.C. sections 247c and 247c-1). The 
Catalog of Federal Domestic Assistance number is 93.977.

J. Where To Obtain Additional Information

    This and other CDC announcements, the necessary applications, and 
associated forms can be found on the CDC home page Internet address-- 
http://www.cdc.gov. Click on ``Funding'' then ``Grants and Cooperative 
Agreements.''
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from:
    Gladys T. Gissentanna, Grants Management Specialist, Procurement 
and Grants Office, Grants Management Branch, Centers for Disease 
Control and Prevention (CDC), 2920 Brandywine Road, Room 3000, Atlanta, 
Georgia 30341-4146. Telephone: (770) 488-2753. Fax: (770) 488-2777. E-
mail address: [email protected].
    For program technical assistance, contact: Janet S. St. Lawrence, 
Ph.D., Division of STD Prevention, Centers for Disease Control and 
Prevention (CDC), 1600 Clifton Road, MS E44, Atlanta, GA 30333. 
Telephone: (404) 639-8298. Fax: (404) 639-8622. E-mail address: 
[email protected].

    Dated: April 24, 2002.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 02-10681 Filed 4-30-02; 8:45 am]
BILLING CODE 4163-18-P